Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) is expected to release its Q2 2026 results before the market opens on Thursday, August 6th. Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) last posted its earnings results on Thursday, May 7th. The specialty pharmaceutical company reported $1.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.52 by $0.24. On average, analysts expect Collegium Pharmaceutical to post $7 EPS for the current fiscal year and $6 EPS for the next fiscal year. Get Collegium Pharmaceutical alerts:Collegium Pharmaceutical Price PerformanceNASDAQ:COLL opened at $36.29 on Thursday.